ST. LOUIS, MO (January 23, 2013) – ulrich medical USA, Inc., today announced record results for the year ending December 31, 2012. The company recorded a 13 percent compound annual growth rate for calendar year 2012 and a 34 percent growth rate for the combined periods of 2011 and 2012.
“Our U.S. management team delivered exceptional, profitable growth again in 2012, especially in light of continued downward price pressures, extensive competition and impending government healthcare changes impacting our industry,” said Christoph Ulrich, Managing Partner, ulrich medical®.
The company also reported a 22 percent growth in case volume for 2012, and a record 58 percent growth in case volume for the combined periods of 2011 and 2012.
“We are extremely proud of our performance in the U.S. market over the past 24 months,” said Hans Stover, President and Chief Executive Officer, ulrich medical USA. “As we kick off our 101st year as a privately held, family-owned and operated company, we are well positioned to capitalize on our premium German engineering and product development as we continue to grow our U.S. business. We will continue to bring our technically-advanced products to the market for the benefit of both patients and surgeons who prefer best-in-class implant technologies.”